Specified Drug Use-results Survey of Betanis Tablets

• Status: Completed
• Trial end date: 2018-01-10
• Target enrollment: 0
• Participant gender: All

Summary

To investigate the effects of mirabegron on the symptoms of glaucoma in overactive bladder (OAB) patients with coexisting glaucoma.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Astellas Pharma Inc
• Treatments: Mirabegron

Criteria

Inclusion Criteria:

• diagnosed as OAB and treated with mirabegron

• diagnosed as glaucoma (including normal tension glaucoma)

• having intraocular pressure measurement conducted more than twice within six months before the start of the mirabegron treatment